Sector valuations Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 156.03 USD | +2.36% |
|
-4.19% | -21.78% |
| 05-13 | Charles River Laboratories, Medipost Sign MoU on GMP-Compliant Testing | MT |
| 05-13 | Charles River Laboratories and Medipost sign non-exclusive MoU to advance GMP testing solutions | RE |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 25.42x | 2.28x | -0.08x | 2.43x | 9.46x | 11.51x | -.--% | 7.52B | |
| 29.79x | 3.68x | 1.33x | 5.27x | 16.35x | 22.99x | 1.11% | 43.7B | |
| 45.93x | 6.35x | 0.28x | 4.67x | 29.84x | 35.42x | -.--% | 34.32B | |
| -18.94x | 13.8x | -0.57x | 288.04x | -17.13x | -16.94x | -.--% | 31.96B | |
| 20.88x | 3.95x | 4.38x | 2.46x | 10.64x | 16.26x | -.--% | 28.62B | |
| 28.72x | 2.13x | 0.84x | 7.43x | 19.09x | 22.94x | 0.43% | 25.12B | |
| 21.6x | 2.26x | 0.75x | 1.89x | 8.33x | 13.19x | 1.23% | 12.71B | |
| -20.95x | 310x | -0.41x | 13.69x | -20.38x | -19.81x | -.--% | 12.4B | |
| 24.76x | 12.4x | 2.15x | 3.93x | 17.89x | 18.76x | -.--% | 12.05B | |
| -28.86x | 41.99x | 1.1x | 2522.33x | -32.48x | -29.03x | -.--% | 9.54B | |
| -22.24x | 8.36x | -1.86x | 2138.74x | -18.74x | -18x | -.--% | 9.36B | |
| 18.37x | 0.95x | -0.54x | 1.44x | 7.42x | 8.2x | -.--% | 8.79B | |
| -22.86x | 20.33x | -0.54x | 5.57x | 136.7x | -378.56x | -.--% | 8.24B | |
| 31.69x | 3.7x | 1.27x | 6.56x | 21.52x | 27.54x | 1.29% | 7.47B | |
| 40.05x | 3.39x | 0.26x | 5.99x | 16.99x | 18.66x | 0.69% | 7.31B | |
| 16.74x | 1.91x | 2.07x | 3.61x | 9.96x | 12.36x | -.--% | 7.26B | |
| Average | 11.88x | 27.34x | 0.65x | 313.38x | 13.47x | -15.91x | 0.3% | 16.65B | |
| Weighted average by Cap. | 15.91x | 21.58x | 0.89x | 204.07x | 11.93x | -0.40x | 0.34% |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition